Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1327, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost effectiveness of celecoxib, rofecoxib in OA and RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Access to resources
Recommend
Celecoxib: low cost alternative in OA and RA
Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. :
Celecoxib: a model therapy for RA and OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :
Celecoxib and rofecoxib equally effective in knee OA
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Rofecoxib cost-effectiveness study results debated
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 455, 2004-01 ,pp. :